Trade NSRX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Nasus Pharma Ltd. (NSRX) is trading at US$4.05, down 1.22% today as of Aug 28, 14:04 EDT. The company has a market capitalisation of US$46.84M. Over the past 52 weeks, NSRX has traded between US$1.98 and US$9.50. On Syfe you can trade NSRX with $0 commission and add it to your watchlist.
| Previous close | US$4.10 |
|---|---|
| Market cap | US$46.84M |
| 52-week range | US$1.98 – US$9.50 |
| Volume | 8.83K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Nasus Pharma Ltd.
Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo in May 2019 and is headquartered in Tel Aviv, Israel.
Year: 2025
Nasus Pharma Says Intranasal NS003 Shows Positive Preclinical Results
Jun 9, 12:37 PM · MT Newswires
Nasus Pharma Ltd. (NSRX) stock is trading at US$4.05, -1.22% from the previous close of US$4.10.
The market cap for Nasus Pharma Ltd. (NSRX) stock is approximately US$46.84M.
The 52-week high for Nasus Pharma Ltd. (NSRX) stock is US$9.50.
The 52-week low for Nasus Pharma Ltd. (NSRX) stock is US$1.98.
Nasus Pharma Ltd. (NSRX) does not currently pay a dividend.
Stay on top of NSRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
